Pharma News, 2020

The agreement with Eli Lilly is for delivery over the two months following an emergency use authorization from the Food and Drug Administration.

AstraZeneca’s Enhertu has scored a priority review from the US Food and Drug Administration (FDA) for the treatment of HER2-positive metastatic gastric cancer.

Sanofi and Regeneron's immunology superstar Dupixent is well on its way to world domination with a flood of new indications in the pipeline.

LONDON (Reuters) - One of the world’s leading COVID-19 experimental vaccines produces an immune response in both young and old adults, raising hopes of a path out of the gloom and economic d...

(Reuters) - Merck & Co Inc on Tuesday said it expects to report results from early-stage studies of two potential COVID-19 vaccines before the end of the year and has advanced an experimen...

Covid-19 patients using aspirin were 43% less likely to be admitted to the ICU.

With a bold prediction that interim data on its COVID-19 shot would be in the public's hands by October, all eyes have been on Pfizer and CEO Albert Bourla.

BERLIN -- Bayer AG said Monday it would pay as much as $4 billion for U.

U.

Researchers are developing a test to diagnose two very serious diseases such as ALS and FTD when the pathologies have not yet appeared, thereby providing doctors and patients with essential informatio...

CAMBRIDGE, Mass.

A world-first double-blind clinical trial, will investigate if a powerful drug used to treat nausea in chemotherapy patients, could alleviate hallucinations in people with Parkinson's.